CroRIS: Structure, Actors, and Patterns of the Drug Market: Croatia in the Context of New Challenges
Principal investigator: Prof. Anita Jandrić Nišević, PhD
CroRIS: Structure, Actors, and Patterns of the Drug Market: Croatia in the Context of New Challenges
Principal investigator: Prof. Anita Jandrić Nišević, PhD
Project team members:
Associates:
Drug abuse and related criminality represent a complex security, health, and social issue in Croatia. The drug market is dynamic and changes under the influence of local and global factors such as digitalization, transnational crime, and socio-economic changes. Despite the existence of individual studies, there is a lack of comprehensive research in the Republic of Croatia that would cover the complex layers and structures of the drug market. The goal of this project is to explore the structure, dynamics, and functioning of the drug market in Croatia through the analysis of participant roles, their network positions, motivation, gender and age characteristics and the relationship between drug use and criminal behavior. To achieve this goal, a survey will be conducted on a sample of participants (n=100) from the criminal justice system, social welfare system, and non-governmental organizations. In addition to a questionnaire constructed specifically for the research, the study will utilize the Lifestyle Criminality Screening Form (Walters, 1991) and the Drug Use Disorders Identification Test (Berman, Berman, Palmstierna, & Schlyter, 2005). A part of the main sample (n=20) will participate in semi-structured interviews. This project, based on an interdisciplinary and mixed methodological approach, will provide empirical insights into relational structures, recruitment dynamics, communication patterns and the social consequences of participation in the drug market. The project will connect the micro-level of individual experiences with the macro-level analysis of institutional and societal responses, thereby influencing the shaping of public policies and improving interventions in the field of drug demand reduction.